top of page
  • Twitter
solo TCR Black logo.png

In-Depth Coverage Of The Irish And European Markets

The U.S. Health Authorities Recommend Reclassification of Cannabis


New York, NY – In a landmark move, the U.S. Department of Health and Human Services (HHS) has proposed reclassifying cannabis as a Schedule III substance under the Controlled Substances Act. This recommendation, detailed in a recent report, marks a significant shift in the federal stance on cannabis, reflecting new scientific understanding and evolving societal views.


The comprehensive HHS document underscores a reevaluation of cannabis abuse potential, medical applications, and safety profile. Drawing upon extensive epidemiological data and recent research findings, the report critically analyzes cannabis composition, its diverse effects, and usage patterns across the country

  • The Department of Health and Human Services (HHS) has recommended reclassifying cannabis as a Schedule III substance under the Controlled Substances Act, marking a significant policy shift.

  • The report presents a comprehensive review of cannabis abuse potential, medical utility, and safety or dependence profile based on current research and epidemiological data.

  • It emphasises new scientific insights and changing societal perceptions about cannabis, considering its chemical composition, effects, and usage patterns.

  • This recommendation reflects a growing acknowledgment of cannabis's medical benefits and a lower risk profile, aligning with evolving attitudes toward cannabis use and regulation.


This HHS document is a pivotal moment in U.S. drug policy, potentially transforming how cannabis is perceived, regulated, and utilised both medically and recreationally


Full HHS Report: Click Here




44 views0 comments
bottom of page